Entheogenix Biosciences

Entheogenix Biosciences is a biotech company formed as a partnership between ATAI Life Sciences and Cyclica. The aim of the company is to develop the next generation of psychedelic-inspired drugs for mental health.

Entheogenix Biosciences

From pitchbook: “Developer of pharmaceutical compounds created with an aim to change the paradigm in which mental health disorders are treated. The company focuses on design and synthesize of new chemical entities from psychoactive seed small molecule compounds, striving to offer innovative medicines for effective treatment of mental health disorders.

Key Staff

  • Srinivas Rao – Co-founder & CEO (CSO of ATAI)
  • Naheed Kurji – Co-founder & Board Member (CEO of Cyclica)
  • Florian Brand – Co-founder & Board Member (CEO of ATAI)
  • Glenn Short – CSO
  • Robert Perni – Consultant
  • Simon Seibold – Operations Lead

News

Become a psychedelic insider!

With a free Blossom membership you will always be in the know.

📰 Weekly newsletter about the psychedelic research

✔️ Unlimited access to our database and original articles

🖊️ Add (private) notes and comments to each page

Make an account